$AKBA Therapeutics $1.25 is already programmed - Long/Call
Fully expect a good earnings report. Positive news from the company. Nothing but good news as far as this company is concerned. Earnings posting this week, and will not disappoint. We could see a nice jump up here.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。